Blogs

In pharmaceutical packaging, maintaining Container Closure Integrity (CCI) is essential to ensure drug products remain sterile, stable, and safe for patient use throughout their entire shelf life. A comprehensive risk management approach evaluates three critical factors: the likelihood of defects occurring (occurrence), the potential impact of those defects on product quality and patient safety (severity), and how effectively those defects can be identified through inspection (detection).

Understanding these dimensions is key to selecting appropriate testing methods and implementing controls that minimize risk. When any of these factors are overlooked or underestimated, the packaging system may fail, leading to compromised drug quality, regulatory non-compliance, and potentially serious health risks. Therefore, a robust CCI strategy is indispensable in pharmaceutical manufacturing.

Understanding Container Closure Integrity (CCI) in Pharma

Container Closure Integrity (CCI) is defined as the ability of a container system to provide a complete barrier against contamination, preserving the product’s intended quality attributes from the point of manufacture until administration. This barrier protects against microbial ingress, moisture, oxygen, and other environmental contaminants that can degrade product efficacy or safety.

CCI testing applies to a wide array of packaging formats, including vials, syringes, ampoules, blister packs, and flexible pouches. Regulatory bodies such as the Food and Drug Administration (FDA) require manufacturers to validate and continuously monitor CCI to mitigate contamination risks. Any failure in CCI can lead to costly product recalls, patient harm, and damage to the manufacturer’s reputation. To meet these stringent requirements, PTI provides advanced deterministic testing technologies. One leading example is Helium Leak Detection , which delivers ultra-sensitive and quantitative results to assure package integrity reliably.

PTI’s Helium Leak Detection: A Proven Standard for High-Sensitivity CCI Testing

PTI’s helium leak detection technology is widely regarded as a gold standard in the pharmaceutical industry for its unparalleled sensitivity and accuracy in detecting minute leaks. Helium, an inert and non-toxic gas, is used as a tracer to identify even the smallest breaches in the container closure system—breaches that conventional methods might miss. The detection capability of PTI’s systems reaches down to 1x10?¹° mbar·L/s, well beyond the minimum requirements for preventing microbial ingress. This makes the technology particularly valuable for products with critical sterility and stability needs, such as biologics, sterile injectables, and cryogenically stored materials.

PTI’s helium leak solutions are also designed to operate under cold-chain and deep-freeze conditions, which are essential for preserving advanced therapies like cell and gene treatments. This combination of sensitivity, versatility, and regulatory compliance has made PTI’s helium leak detection a trusted choice for pharmaceutical companies worldwide seeking the highest level of package integrity assurance.

Applications of Helium Leak Detection

• Pharmaceuticals & Biologics: Helium leak detection is integral in confirming the integrity of various packaging types such as vials, syringes, bottles, blister packs, and foil pouches. It is particularly effective for complex, multi-chamber combination products where traditional methods may fall short, thus preventing contamination and ensuring the sterility of sensitive drug formulations and biologics.
• Medical Device Industry: In the medical device field, helium leak testing validates the seal integrity of critical components like implantable devices, catheters, and diagnostic tools. Ensuring these devices remain sealed and functional throughout their lifecycle is vital to patient safety and device performance, especially for life-saving applications.

Ensuring robust Container Closure Integrity is vital to pharmaceutical quality control and patient safety. A thorough understanding of risk occurrence, severity, and detection enables manufacturers to implement targeted and effective inspection strategies. PTI’s helium leak detection technology exemplifies how advanced, deterministic methods can provide the highest level of sensitivity and reliability, identifying even the smallest leaks that threaten packaging integrity. By integrating these sophisticated testing approaches, pharmaceutical and medical device manufacturers can strengthen their quality assurance programs, comply with evolving regulatory standards, and ultimately safeguard the health of patients worldwide.

In sectors where maintaining product integrity is critical, such as pharmaceuticals, medical devices, and biotechnology, ensuring secure, leak-proof packaging is essential. Even the slightest defect in the seal can compromise sterility, reduce efficacy, and pose serious safety risks. Packaging failures can lead not only to product recalls and regulatory penalties but also to damage to brand reputation and patient trust.

To prevent such outcomes, manufacturers are increasingly adopting advanced leak detection technologies that offer both precision and reliability. PTI’s advanced helium leak testing solutions provide exceptional sensitivity and can identify micro leaks that conventional methods often miss. Designed to meet strict industry regulations, these systems support a wide range of packaging types and help companies maintain quality assurance across diverse applications.

Why Helium? The Ideal Tracer Gas

• Non-toxic and Inert: Helium is chemically inert and non-reactive, ensuring no interaction with the product or packaging materials.
• Small Atomic Size: Its minute atomic size allows it to permeate even the tiniest leaks, making detection highly sensitive.
• Low Atmospheric Concentration: With minimal natural presence, helium provides a clear signal against background noise.
• Non-condensable and Non-flammable: Helium's properties ensure safety during testing procedures.

Ensuring Integrity with PTI Helium Testing

PTI’s helium leak detection method offers high-precision leak detection for critical packaging applications. Using helium as a tracer gas enables the identification of extremely small leaks with exceptional sensitivity. The SIMS 1915+ system developed by PTI can detect leak rates as low as 1 x 10?¹° mbar·L/sec, ensuring thorough evaluation of package integrity. This method is highly effective for a range of packaging types, including vials, syringes, blister packs, and combination products.

PTI’s solutions are aligned with regulatory requirements such as USP <1207> and 21 CFR Part 11, supporting compliance and audit readiness. The system also allows for reliable, repeatable results through calibrated standards and advanced data acquisition. Its flexibility across multiple industries, including pharmaceuticals, biotechnology, and medical devices, makes it a trusted choice for quality assurance. With PTI’s helium leak testing, manufacturers can confidently ensure product safety, integrity, and regulatory compliance. The technology also supports cold temperature testing, making it ideal for products that require storage and handling under controlled conditions. By integrating helium leak testing into their quality control programs, companies gain actionable insights and strengthen risk mitigation efforts.

Applications Across Industries

PTI's helium leak testing methods are employed across various sectors to ensure product integrity:

• Pharmaceuticals: Verifying the sterility and efficacy of drug packaging.
• Medical Devices: Ensuring the functionality and safety of medical equipment.

In conclusion, precision leak detection is vital for maintaining product quality and safety in highly regulated industries. PTI’s helium leak testing technology provides the advanced sensitivity needed to detect even the smallest packaging breaches. By enabling manufacturers to meet strict compliance standards, PTI helps protect brand reputation and ensure customer trust.

Helium leak testing services are precision methods used in the pharmaceutical and medical device industries to detect even the smallest leaks in packaging. Using helium as a tracer gas, this technique ensures sterile barriers remain intact, which is critical for patient safety and product efficacy. It is especially valuable for testing sealed containers like vials, blister packs, and pre-filled syringes. By verifying seal integrity, helium leak testing supports regulatory compliance with strict industry standards. This process helps manufacturers reduce the risk of contamination, product recalls, and compromised shelf life.

What Helium Leak Testing Services Include?

PTI's Helium Leak Testing Services offer comprehensive solutions for ensuring the integrity of pharmaceutical and medical device packaging. Our services encompass a range of offerings to support clients in maintaining high-quality standards and regulatory compliance.

• System Installation & Qualification: This includes installation, operational, and performance qualification (IQ/OQ/PQ) to meet strict regulatory standards.
• Method Development & Feasibility Testing: Offers lab-scale studies or on-site validation to develop compliant and effective test methods before full implementation.
• Onsite or In-House Testing: Flexible testing options at client facilities or PTI’s Centres of Excellence, including capabilities for cold storage testing.
• Training & Support Services: Comprehensive on-site training and service contracts for ongoing maintenance, calibration, and repairs.
• Regulatory Compliance & Accuracy: Deterministic testing method aligned with USP <1207>, delivering precise, reliable results that eliminate subjectivity and support compliance.

Benefits of Helium Leak Testing in Packaging

Helium-based testing is an advanced solution for ensuring container closure integrity (CCI) in pharmaceutical packaging. By using helium, a small, inert, and non-toxic gas, as a tracer, this method delivers unmatched sensitivity and precision in leak detection.

Key Benefits:

• Unmatched Sensitivity: Helium leak detection can detect extremely small leaks (down to 1×10¹° mbar·L/sec), far beyond the capabilities of traditional methods. This makes it ideal for critical pharmaceutical applications where even microscopic breaches matter.
• Quantitative, Reliable Data: The method provides measurable leak rates, enabling not just pass/fail results but also in-depth comparisons across package types, materials, production lines, and storage conditions.
• Fast and Efficient Testing: Most helium test cycles are under 1 minute, with some as short as 30 seconds, supporting rapid testing, even on 100% of production units.
• Supports Regulatory Compliance: With growing regulatory emphasis on deterministic CCI testing, helium leak detection aligns perfectly with modern standards, helping eliminate reliance on traditional sterility tests and ensuring robust contamination prevention.

Helium leak testing services play a vital role in modernizing pharmaceutical and medical device packaging processes. They provide manufacturers with advanced tools to proactively ensure product safety and quality. With its precision and adaptability, helium testing supports both innovation and risk mitigation across packaging lines. As the industry moves toward more deterministic and data-driven quality control, helium leak detection stands out as a trusted and future-ready solution.

Ensuring the sterility and integrity of injectable drug products has always been a critical requirement in pharmaceutical manufacturing. As regulatory standards evolve, companies must continuously reassess their quality control strategies to keep pace. One such change is the upcoming implementation of USP <382>, a chapter focused on evaluating the functional performance of elastomeric closures used in injectable pharmaceutical packaging.

Slated to take effect on December 1, 2025, USP <382> places increased emphasis on deterministic, science-based testing approaches. Among the various technologies available, Helium Leak Detection (HLD) is gaining traction for its precision and sensitivity in assessing container closure integrity (CCI). This blog explores how HLD can help manufacturers meet the new regulatory expectations under USP <382> while reinforcing a proactive quality assurance framework.

Understanding USP <382>: What’s Changing?

USP <382>, officially titled “Elastomeric Closure Functionality in Injectable Pharmaceutical Packaging/Delivery Systems,” is designed to supplement existing requirements around parenteral container systems. While USP <1207> remains the cornerstone for CCI testing, <382> zooms in on the performance of elastomeric components—particularly their ability to maintain closure integrity across a product’s shelf life.

Key focus areas include:

• Functional testing of closure systems
• Suitability and robustness of elastomers under various stress conditions
• Encouragement of deterministic testing methods for closure integrity

Simply put, the chapter is aimed at ensuring that elastomeric closures reliably protect the drug product from microbial ingress or leakage—throughout storage, handling, and administration.

The Role of Helium Leak Detection

Helium Leak Detection is a deterministic test method that utilizes helium as a tracer gas to identify leaks in a sealed container system. Leveraging mass spectrometry, the technique can detect extremely small quantities of helium escaping through microscopic breaches, offering quantifiable, reproducible results that are difficult to achieve with traditional probabilistic methods.

Why HLD Stands Out:

• Ultra-high sensitivity — capable of detecting leaks as small as 1 x 10?¹° mbar·L/s
• Objective and repeatable results — ideal for batch comparisons and statistical evaluations
• Supports validation and process control — with numerical leak rate data for trend monitoring

In the context of USP <382>, these attributes align perfectly with the chapter’s push for more rigorous, functional integrity testing.

Bridging USP <382> Expectations with HLD

• Meeting Functional Integrity Requirements

At its core, USP <382> asks manufacturers to demonstrate that closures maintain integrity under real-world conditions—such as aging, thermal stress, and physical transport. Helium Leak Detection allows for a direct assessment of the seal quality by detecting minute channel leaks or closure failures that might otherwise go unnoticed.

For elastomeric components, this kind of sensitivity is essential. These materials may experience subtle changes in elasticity or sealing behavior over time, which HLD can readily detect.

• Deterministic vs Probabilistic: Regulatory Preference

While methods like dye ingress or microbial challenge have long been used for CCI, they fall short in terms of quantifiability and reproducibility. Helium Leak Testing, on the other hand, is deterministic—producing consistent, scientific measurements rather than subjective pass/fail outcomes.

This determinism is not just preferred—it’s increasingly expected. Both the FDA and EMA have shown growing support for deterministic methods as part of a risk-based approach to product quality. By implementing HLD, companies position themselves to meet both USP <382> and broader global regulatory expectations.

• Quantitative Analysis and Leak Rate Thresholds

Unlike older methods that rely on visual inspection, HLD provides a numerical value for the leak rate. This allows manufacturers to:

• Define acceptance criteria based on leak rate thresholds
• Establish control limits during stability testing
• Perform trend analysis across production lots

These capabilities are especially valuable when developing or validating closure systems for new drug products, where precise data can support sound decision-making.

USP <382> represents a critical step forward in pharmaceutical packaging integrity standards. It challenges manufacturers to go beyond tradition and adopt rigorous, functional testing approaches to safeguard injectable drug products. Helium Leak Detection offers a proven, scientifically robust method to meet these demands—delivering the precision, reproducibility, and sensitivity that regulators now expect.As the compliance deadline approaches, investing in a deterministic, helium-based CCI testing strategy isn’t just advisable—it’s becoming essential.

Life science companies are facing growing challenges in storing complex drug formulations, especially as advanced biologics and cell and gene therapies become more common. These innovative treatments often require ultra-low temperature storage conditions to maintain stability, potency, and safety.

Traditional cold chain solutions are no longer sufficient to meet the stringent demands of modern pharmaceuticals. Companies must now invest in specialized equipment, real-time monitoring, and rigorous quality control systems. Regulatory expectations have also intensified, pushing organizations to adopt robust validation and documentation practices.

To support these efforts, PTI’s advanced helium leak detection technology plays a vital role in ensuring packaging integrity under ultra-low temperature conditions.

Challenges Faced in Storing Complex Drug Formulations at Ultra-Low Temperatures

Storing advanced drug formulations at ultra-low temperatures isn’t as simple as just putting them in a freezer. These extreme conditions can create several serious challenges. Here's a look at what makes it so tough:

• Packaging Materials Can Become Brittle: Not all materials are built to handle the deep freeze. Rubber stoppers, plastic parts, and even some glass vials can become brittle and crack when exposed to ultra-low temperatures. This can break the protective seal around the medicine, risking contamination.
• Shrinkage Can Break the Seal: Different packaging components shrink at different rates in the cold. For example, the glass vial, the rubber stopper, and the metal cap all contract differently. Even tiny changes in size can break the seal and let in unwanted air or moisture, things that can damage the drug or reduce its effectiveness.
• Pressure Changes During Shipping: Drugs that are stored in dry ice or liquid nitrogen often travel by air. During flights, changes in air pressure and temperature can cause stress on the packaging. This makes it easier for small leaks to form—leaks that may go unnoticed but can be harmful.
• Old Leak Detection Methods Aren’t Good Enough: Traditional ways of checking for leak, like using dyes or microbial tests, don’t work well for these ultra-cold products. They’re not sensitive enough, and they can even damage the product during testing. Plus, they can’t really mimic the freezing and thawing that happens in real storage and shipping.

How does Helium Leak Detection Work with Ultra-low Temperatures?

Helium leak testing with ultra-low temperatures identifies microscopic leaks in packaging that may occur under extreme cold, especially with biologics stored below -20°C. At these temperatures, elastomeric components like rubber stoppers can undergo physical changes, leading to leaks at primary seal areas, which aren't detectable at room temperature. The process involves conditioning the sealed package to ultra-low temperatures, often as low as -80°C, and introducing helium tracer gas to detect any leaks.

Helium, being small and inert, passes through even the tiniest leaks, enabling precise detection. Specialized systems like PTI’s LT80 allow simultaneous temperature conditioning and leak testing, providing real-time data and ensuring package integrity. The LT80 system is compatible with existing PTI SIMS units and helps meet regulatory standards like USP 1207. By using helium leak detection, manufacturers gain insights into the best materials and designs for packaging under extreme cold, ensuring product quality and safety.

To meet the demands of ultra-sensitive drug formulations, life science companies are adopting advanced testing technologies like helium leak detection. This ensures packaging integrity under extreme cold conditions, safeguarding product stability and efficacy. As therapies become more complex, maintaining control over storage environments is essential for quality and compliance. These innovations ultimately enhance patient safety and strengthen supply chain reliability.

Helium leak testing is considered the gold standard for detecting micro leaks in packaging due to its unmatched reliability and sensitivity. It is essential in ensuring the safety, quality, and longevity of packaged products across various industries. This method is trusted by regulatory bodies and manufacturers alike for meeting strict quality assurance standards. Its ability to consistently identify even the most minute leaks has set a benchmark for leak detection practices. As such, helium leak testing has become an integral part of modern packaging validation and integrity testing protocols. Its widespread adoption reflects the growing demand for precision in quality control. Ultimately, it helps protect consumer health, maintain brand reputation, and ensure compliance with regulatory requirements.

Importance of Micro-Leak Detection for Container Integrity

Micro-leak detection helps ensure the integrity of containers used in packaging, especially in industries like pharmaceuticals and medical devices. Even the smallest leaks can compromise product sterility, safety, and effectiveness. Detecting micro-leaks prevents contamination from external elements such as moisture, oxygen, or bacteria. This is particularly important for products sensitive to environmental changes or those that require a sterile barrier. Maintaining container integrity also supports regulatory compliance and helps avoid costly recalls or product failures. Early detection of leaks during production promotes consistent quality assurance and minimizes the risk of damage during storage and transport. Ultimately, micro-leak detection strengthens both product protection and user safety.

Technology Overview

Helium leak testing is a method used to detect leaks in various enclosed or sealed systems by employing helium as a tracer gas. These systems can include a wide range of packaging formats, such as vials, syringes, cartridges, foil blister cards, bottles, and foil pouches or sachets, where helium can be introduced before or during the leak test cycle. This technique relies on a highly sensitive mass spectrometer detector to precisely assess the integrity of each sealed package or system.

Helium leak detection provides reliable assurance of the integrity and safety of sealed systems across a wide range of industries. Its exceptional sensitivity and accuracy make it indispensable for identifying even the smallest leaks in critical applications such as pharmaceuticals and medical device. By utilizing helium as a tracer gas, manufacturers can uphold strict quality control measures and comply with regulatory standards. This technology’s ability to deliver consistent and reliable results helps prevent contamination, enhance product safety, and optimize manufacturing efficiency. As industries continue to advance, helium leak detection will remain a trusted and essential solution for maintaining the highest standards of quality and safety.

In conclusion, helium leak testing has rightfully earned its place as the gold standard for detecting microleaks in packaging due to its unmatched sensitivity, reliability, and consistency. It is essential for safeguarding product integrity, ensuring consumer safety, and meeting stringent regulatory requirements across various industries. By enabling early detection of even the smallest leaks, this method helps prevent contamination, reduce recalls, and maintain brand trust. Its proven effectiveness and adaptability make it an indispensable tool in modern quality assurance processes. As the demand for higher standards in packaging continues to grow, helium leak testing will remain a critical component in ensuring product safety and performance.

Container Closure Integrity (CCI) testing is used to verify that medical device packaging maintains a consistent barrier against external contaminants over time. This process helps determine whether the seal and structure of a package can effectively prevent the ingress of moisture, oxygen, or microorganisms. In the context of medical device manufacturing, the packaging must not only preserve the device’s sterile condition but also maintain its functionality until it reaches the end user. CCI testing enhances quality control processes, offering manufacturers greater confidence that their packaging will hold up under real-world conditions. Among the various CCI testing methods available, helium leak detection is recognized for its exceptional sensitivity and consistent accuracy. This makes it particularly well-suited for high-risk devices, where even the smallest breach in packaging could lead to significant safety concerns.

Importance of Leak Detection

Effective leak detection in packaging safeguards the sterility and functionality of pharmaceutical containers and medical devices throughout their shelf life. It helps prevent contamination from external elements such as bacteria and moisture, which can compromise patient health. Early identification of leaks supports efficient quality control and minimizes the risk of defective products reaching the market. It also enables manufacturers to refine packaging materials and sealing processes for improved reliability. In high-risk applications like implants or surgical instruments, even minor packaging failures can lead to serious consequences, making leak detection a critical safeguard. Leak detection techniques help manufacturers identify such defects before products are released. This not only enhances product reliability but also supports a consistent standard of quality in production. By integrating helium leak testing into quality control protocols helps prevent situations that could lead to contamination, product recalls, or patient exposure to unsafe devices.

How does Helium Leak Detection work?

Helium leak detection works by using helium gas as a tracer to identify and quantify leaks in sealed packages or containers. The process begins by introducing helium into the test item, either by direct injection or placing it in a helium-rich environment. The test item is then placed in a vacuum chamber, where any helium escaping through potential leaks is drawn out. A highly sensitive mass spectrometer detects the escaping helium by measuring the partial pressure of the gas. Inside the spectrometer, the helium atoms are ionized, accelerated, and deflected by a magnetic field. The resulting ions generate an electric current that corresponds to the size of the leak. This current is amplified and displayed as a leak rate, allowing precise detection of even the smallest defects.

In conclusion, Helium leak detection is a highly effective method for ensuring container closure integrity in pharmaceutical and medical device packaging. Its sensitivity allows for the detection of even the smallest leaks that could compromise sterility. By identifying packaging flaws early, manufacturers can enhance product quality and reduce the risk of recalls. This method also supports compliance with strict regulatory requirements in the healthcare industry. Overall, helium leak detection contributes significantly to maintaining the quality and reliability of medical devices.

Ensuring package integrity in pharmaceuticals and life sciences is crucial for maintaining the safety, efficacy, and sterility of products. Packaging must provide a secure barrier against contamination, environmental factors, and physical damage. Advanced testing methods, such as helium leak detection, is used to identify any defects or leaks in packaging that could compromise the product. Regulatory standards require stringent testing to ensure that pharmaceutical and life science products meet quality and safety guidelines. By maintaining package integrity, manufacturers can ensure that their products remain effective, safe, and compliant with industry regulations.

Package Integrity Testing with PTI's SIMS 1915+

The Seal Integrity Monitoring System (SIMS) 1915+ is an advanced helium-based leak detection solution designed to ensure the integrity of pharmaceutical and medical device packaging. By utilizing helium as a tracer gas, the system provides highly sensitive and quantitative leak detection, offering accuracy far beyond traditional methods like vacuum bubble and dye penetration testing. It is particularly effective for testing a wide range of pharmaceutical products, including vials, syringes, cartridges, and blister cards, ensuring the sterility and safety of these sensitive items.

The SIMS 1915+ offers a remarkable sensitivity of 1 x 10-10 mbar/L/sec, generating detailed data sets that provide a deeper understanding of the package’s integrity. Custom-built to meet specific client requirements, it ensures reliable performance under both ambient and cryogenic conditions, making it an ideal solution for life sciences packaging testing.

Advantages of using SIMS 1915+

• Cold Temp Testing: Accurate leak detection down to -160°C.
• Enhanced Integrity: Identifies leaks not visible at room temperature.
• Improved Quality & Safety: Ensures product integrity at storage temperatures.
• Versatility: Customizable to meet specific needs.
• High Sensitivity: Detects even the smallest leaks.
• 21 CFR Part 11 Data Integrity Software - ETHOS

SIMS 1915+ Options

• Low-Temperature Add-on Systems LT80, LT85 and LT150 for ultra-cold CCI testing utilizing helium leak detection methods.
• Various sizes of Vacuum Test Fixtures to accommodate all package types and sizes.
• Helium leak testing for non-vacuum chamber applications with custom test fixtures.
• External helium leak standards in a variety of leak rate ranges.
• Helium Sniffer Probe - for determining leak sites on a site-by-site basis.
• Vacuum clamps, O-ring seals, chamber gaskets, and other components.

In conclusion, the PTI SIMS 1915+ Helium Leak Detector is a crucial tool in ensuring the integrity and safety of pharmaceutical and life sciences packaging. Its ability to detect even the smallest leaks, including under cryogenic conditions, ensures that sensitive products remain sterile and effective. Ultimately, the SIMS 1915+ provides reliable performance, contributing to the overall safety and compliance of life sciences products

The pharmaceutical industry depends on deep cold storage for delicate drug and biologic formulations, but traditional packaging may not withstand extreme temperatures, leading to potential leaks and degradation. PTI’s LT add-on units for SIMS helium leak detectors offer an innovative solution by evaluating package integrity at temperatures ranging from 0°C to -160°C. This advanced technology helps manufacturers identify defects and optimize packaging designs, ensuring superior performance under deep cold storage conditions.

LT Low Temperature Systems for SIMS Helium Leak Detectors

PTI’s SIMS 1915+ LT add-on units combine advanced helium leak detection with precise temperature conditioning to provide an effective solution for cold temperature leak detection. These systems are designed to test packages at ultra-low temperatures, ranging from 0°C to -160°C, ensuring package integrity is maintained in deep cold storage environments. Integrating a chiller allows the system to condition and monitor the package temperature while simultaneously conducting helium leak tests. Helium is introduced into the package, and any leaks, particularly in critical areas like elastomeric seals, are detected by the SIMS 1915+ helium leak detector.

This technology enables manufacturers to detect potential leaks in materials like elastomeric closures, which may become brittle or undergo physical changes at low temperatures. By evaluating package performance under cold conditions, manufacturers can optimize packaging designs to prevent leaks and maintain product quality. The LT systems improve product quality by identifying and addressing leaks early in the packaging process. Additionally, the system ensures compliance with regulatory standards such as USP 1207 and USP 382, ensuring product safety and reliability.

By combining precise temperature control with advanced helium leak testing, these systems help manufacturers identify and address potential leaks, particularly in critical areas like elastomeric seals. This technology not only enhances product quality but also improves packaging design and component evaluation to meet regulatory standards. Ultimately, the LT systems ensure the safety, reliability, and performance of delicate drug and biologic formulations in cold storage environments, ultimately protecting life-saving drugs and therapies.

Accurate leak detection is crucial in pharmaceutical packaging to ensure the integrity and safety of the product. Leaks can lead to contamination, reduced efficacy, or compromised shelf life, posing risks to both patients and manufacturers. Different packaging types, such as blister packs, vials, and syringes, require tailored detection methods to address their unique characteristics. Implementing reliable and sensitive leak detection systems helps maintain compliance with industry standards and ensures the highest quality and safety for pharmaceutical products. Let's understand how SIMS 1915+ helium leak detection ensures package integrity across diverse packaging types.

Helium Leak Detection using SIMS 1915+

The Seal Integrity Monitoring System (SIMS) 1915+ utilizes a helium-based leak detection method, proven effective for a wide range of pharmaceutical and medical device packaging systems. By using helium as a tracer gas, the system allows for highly sensitive, quantitative testing that surpasses traditional vacuum bubble and dye penetration methods. This approach is ideal for testing various pharmaceutical and parenteral products such as vials, syringes, cartridges, and blister cards.

SIMS 1915+ offers quantitative analysis with a sensitivity as low as 1 x 10-10 mbar/L/sec, providing detailed data sets instead of basic pass/fail results. It supports testing under both ambient and cryogenic storage conditions. Each SIMS 1915+ Helium Leak Testing system is custom-built to meet client-specific standards and packaging configurations.

Advantages of using SIMS 1915+

• Cryogenic Testing: Accurate leak detection down to -160°C.
• Enhanced Integrity: Identifies leaks not visible at room temperature.
• Improved Quality & Safety: Ensures product integrity at storage temperatures.
• Versatility: Customizable to meet specific needs.
• High Sensitivity: Detects even the smallest leaks.
• Rapid test cycle
• 21 CFR Part 11 Data Integrity Software

In conclusion, the PTI SIMS 1915+ provides advanced, highly sensitive leak detection for a wide range of pharmaceutical and medical device packaging, ensuring product integrity even in extreme conditions. With custom-built fixtures and helium-based testing, it delivers precise, quantitative results that surpass traditional methods. The system's versatility allows it to meet the unique needs of various packaging configurations, offering reliable and accurate data. Its ability to detect even the smallest leaks ensures enhanced quality, safety, and compliance in the pharmaceutical and biotechnology industries.

The integrity of packaging is crucial in maintaining the safety, sterility, and quality of pharmaceutical products. Ophthalmic bottles, such as those for eye drops and ocular medications, demand strict quality control to ensure reliability. The PTI SIMS 1915+ provides a precise solution for evaluating the package integrity of these bottles. By introducing helium into the packaging and detecting any leaks, even the most minute breaches can be identified. This advanced testing method ensures the medication's potency and sterility, ultimately safeguarding patient health.

SIMS 1915+ for Ophthalmic bottles

PTI Seal Integrity Monitoring System (SIMS) Model 1915+ is a helium-based leak detection system specifically designed for a broad range of pharmaceutical packaging applications, including ophthalmic bottles, pre-filled syringes, vials, cartridges, combination products, and blister cards. By using helium as a tracer gas, the system allows for precise quantitative evaluation of packaging integrity, offering enhanced accuracy over traditional vacuum bubble and dye penetration tests. This approach facilitates detailed comparisons across various packaging materials, formats, production line conditions, and storage stability, supporting the entire product lifecycle.

The SIMS 1915+ offers sensitivity levels as low as 1 x 10^-10 mbar/L/sec. The SIMS 1915+ is housed in a durable console frame with a stainless-steel working surface and an optional dual test port manifold. Designed as a freestanding unit, it includes locking wheels and an articulating arm system for easy operation and portability. Each SIMS 1915+ unit is tailored to meet the specific requirements and packaging configurations of the customer, including those for ophthalmic bottles.

SIMS 1915+ Options:

• Low-Temperature Add-on Systems LT80 and LT150 for ultra-cold CCI testing using helium leak detection methods.
• A range of Vacuum Test Fixtures available to suit different package sizes and types.
• Helium leak testing for non-vacuum chamber applications, with custom test fixtures available.
• External helium leak standards offered in various leak rate ranges.
• Helium Sniffer Probe to detect leak sites individually.
• Vacuum clamps, O-ring seals, chamber gaskets, and other essential components.
• Vacuum clamps, O-ring seals, chamber gaskets, and other essential components.

The SIMS 1915+ is an essential tool for ensuring the quality and safety of ophthalmic products. By detecting and addressing potential leak sources, manufacturers can prevent contamination, product degradation, and harm to patients. This highly sensitive and accurate system protects the integrity of ophthalmic packaging, maintaining the potency and sterility of the medication. Through thorough testing and analysis, manufacturers can optimize packaging design and production processes, ultimately improving patient safety and satisfaction.

Pharmaceuticals often require deep cold storage, but standard packaging may fail at such extreme temperatures, risking leaks and product damage. PTI's LT add-on units for their SIMS helium leak detectors address this by evaluating package integrity from 0°C down to -160°C, enabling manufacturers to identify packaging defects and optimize designs for these challenging conditions.

How does it transform the integrity of ultra-cold storage?

PTI's LT system, used with their SIMS helium leak detector, transforms ultra-cold storage integrity by enabling leak detection at temperatures as low as -160°C. This allows manufacturers to identify leaks that only occur at these extreme temperatures, specifically addressing the challenges posed by elastomeric component changes and primary seal failures, common in deep cold storage. By testing at actual storage temperatures, the LT helps optimize packaging design and assembly, minimizing leakage and ensuring product integrity in compliance with USP 1207 and USP 382, ultimately improving the safety and efficacy of temperature-sensitive pharmaceuticals.

Low-Temperature Helium Leak Testing

Integrating a chiller with a helium leak detector, such as the LT, enables precise package testing at temperatures as low as -160°C. This capability helps manufacturers detect potential leaks in packaging components, including elastomeric closures, that may arise under extreme cold conditions. Gaining insights into packaging performance at these temperatures allows manufacturers to enhance product integrity, minimize waste, and meet rigorous regulatory requirements.

The LT series offers several significant benefits for the pharmaceutical industry:

• Precision Leak Detection at Ultra-Low Temperatures – Effectively identifies leaks in packaging materials under extreme cold conditions.
• Improved Product Integrity – Protects sensitive pharmaceutical products from degradation, ensuring their stability and efficacy.
• Minimized Product Waste – Reduces losses caused by leaks and spoilage, leading to better inventory management and cost savings.
• Regulatory Adherence – Complies with stringent guidelines such as USP 1207, ensuring products meet the highest safety and quality standards.

With the pharmaceutical industry's increasing dependence on deep cold storage for temperature-sensitive products, reliable packaging is essential. Helium leak detection offers a precise and effective method for evaluating container closure integrity, ensuring that packaging remains intact in ultra-low temperature environments. By detecting and addressing potential leaks early, manufacturers can maintain product quality, reduce waste, and ultimately enhance patient safety.

Blister packs are widely used across various industries, including pharmaceuticals, to protect products from external contamination and environmental factors such as moisture, air, and light. Maintaining the integrity of these packages is paramount for ensuring product quality and adhering to regulatory standards. Among the available leak testing methods, helium leak testing has proven to be a highly reliable and precise technique for verifying the integrity of blister packs. This method not only ensures compliance with stringent industry regulations but also enhances product reliability by identifying potential packaging failures before they reach the end-user. Therefore, helium leak testing offers a significant advantage in maintaining the quality and safety of goods packaged in blister packs.

Key Standards for Blister Package Leak Detection 

• USP 1207: Guidance for container integrity testing principles and methods.
• ASTM Standards: Standards for packaging materials and testing methods.
• FDA Regulations: Regulations for packaging and labelling, including leak prevention.

Factors influencing the sensitivity and accuracy of helium leak detection 

• Exceptional Sensitivity: Detects even the smallest leaks that could compromise product quality.
• High Throughput: Ideal for high-volume production environments, ensuring efficient testing.
• Product Safety: Helium is non-reactive and inert, guaranteeing no product contamination.
• Precise Leak Identification: Accurately pinpoints the location and size of leaks
• Cost-Effective: Reduces product loss and enhances packaging integrity, resulting in long-term cost savings.
• Regulatory Compliance: Meets stringent industry standards for product safety and quality assurance.

Why is Helium Leak Detection Ideal for Blister Pack Testing? 

Helium is considered an ideal choice of tracer gas because of multiple reasons. Helium is non-toxic, non-flammable, non-condensable and its presence in the atmosphere is not more than 5ppm. The small atomic size of helium makes it easier to pass through leaks. Since helium does not react with other materials, it is relatively safe to use. Additionally, compared to other tracer gases helium is less expensive and is available in multiple cylinder sizes. Under this method, a helium leak detector otherwise known as Mass Spectrometer Leak Detector (MSLD) is used to identify and calculate size of the leak. The test part is first connected to a leak detector and then the tracer gas, helium is introduced. In the presence of a leak, helium escapes from the test parts and this partial pressure is measured and results are displayed on the meter.

In conclusion,helium leak detection is indispensable for ensuring the integrity of blister packs in the pharmaceutical and medical device industries. Its high sensitivity guarantees the detection of even minute leaks, safeguarding product safety and ensuring regulatory compliance. PTI's expertise and customized solutions empower manufacturers to seamlessly integrate this vital testing method into their quality assurance processes, thereby protecting both product integrity and patient health.

The integrity of packaging plays a critical role in ensuring the safety, sterility, and quality of pharmaceutical products. Ophthalmic bottles designed for eye drops and other ocular medications require stringent quality control to ensure product integrity. Helium leak detection offers a precise method to assess the package integrity of these bottles. By introducing helium gas into the bottle and monitoring for leakage, even the smallest breaches can be identified. This advanced technique safeguards the medication's potency and sterility, ultimately protecting patient health.

Ophthalmic Bottles - Applications

Eye Drops

• Single-use and multi-use bottles
• Dropper bottles
• Pump bottles

Contact Lens Solutions

• Bottles
• Pouches

Specialized Eye Care Products

• Diagnostic solutions
• Therapeutic eye drops

CCI testing of bottles using helium leak detection

To ensure the quality and safety of ophthalmic bottles, helium leak detection is employed as a sensitive and highly accurate method. This technique involves introducing helium gas into the bottle and then monitoring for any leakage. The bottles are subjected to a vacuum chamber, exposing the closure and neck to vacuum pressure. A small hole is created in the bottle base to allow helium gas to fill the interior. Helium gas is introduced into the bottle and sensitive detectors monitor for any leakage. By identifying and addressing potential leak sources, manufacturers can prevent contamination, product degradation, and patient harm. This method is particularly effective for detecting even the smallest leaks, ensuring the integrity of the packaging and safeguarding the quality of the ophthalmic product.

Technology Overview

• Helium gas, employed as a tracer, is utilized to detect and pinpoint leaks within ophthalmic packaging.
• Helium gas, escaping through any potential breach in the packaging, undergoes ionization when exposed to an electric beam.
• The ionized helium ions, generated from the leaked gas, are subjected to analysis based on their mass-to-charge ratio.
• By meticulously measuring the concentration of helium ions within the system, the leak rate can be precisely determined.
• The accurate determination of the leak rate enables a comprehensive assessment of the overall integrity of the ophthalmic packaging.

Helium leak detector is a critical tool for ensuring the quality and safety of ophthalmic products. By identifying and addressing potential leak sources, manufacturers can prevent contamination, product degradation, and patient harm. This sensitive and accurate method safeguards the integrity of ophthalmic packaging, protecting the potency and sterility of the medication. Through rigorous testing and analysis, manufacturers can optimize packaging design and production processes, ultimately enhancing patient safety and satisfaction.